Restart Life Sciences Corp. (CSE:HEAL)
0.0950
+0.0150 (18.75%)
Apr 28, 2026, 1:49 PM EST
Restart Life Sciences Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.64M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRestart Life Sciences News
- 14 hours ago - Restart Life Sciences' Wholly Owned Subsidiary Holy Crap Foods Launches on Walmart Canada's Digital Marketplace - Newsfile Corp
- 5 days ago - Restart Life Sciences' Wholly Owned Subsidiary Holy Crap Foods Reports over 500,000 Units Sold, Highlighting Strong Consumer Adoption - Newsfile Corp
- 6 days ago - Restart Life Sciences Provides Performance and Revenue Trend Update on Newly Acquired Superseed Cereals and Oatmeal Brand Portfolio - Newsfile Corp
- 6 weeks ago - Restart Life Highlights Certified Manufacturing Platform to Drive Margin Expansion and Distribution Growth - Newsfile Corp
- 2 months ago - Restart Life Announces Collaboration with University of Manitoba's Centre for Food Technology and Research - Newsfile Corp
- 2 months ago - Restart Life Sciences Closes Acquisition of Holy Crap Foods - Newsfile Corp
- 2 months ago - Restart Life Sciences Executes Definitive Agreement to Acquire Holy Crap Foods - Newsfile Corp
- 4 months ago - Restart Life Receives Aggregate Gross Proceeds of Approximately $590,000 from Warrant Exercises and Loan - Newsfile Corp